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Abstract 
Type 1 diabetes mellitus (T1DM) is a major subtype of diabetes and is usually 
diagnosed at a young age with insulin deficiency. The life expectancy of T1DM patients 
have increased substantially in comparison with that three decades ago due to the 
availability of exogenous insulin, though it is still shorter than that of healthy people. 
However, the relation remains unclear between T1DM and dementia as an aging-
related disease. We conducted a systematic review of existing literature on T1DM and 
cognition impairments by carrying out searches in electronic databases Medline, 
EMBASE, and Google Scholar. We restricted our review to studies involving only 
human subjects and excluded studies on type 2 diabetes mellitus or non-classified 
diabetes. A meta-analysis was first performed on the relationship between T1DM and 
cognitive changes in youths and adults respectively. Then the review focused on the 
cognitive complications of T1DM and their relation with the characteristics of T1DM, 
glycemic control, diabetic complications, comorbidities, and others. First, age at onset, 
disease duration, and glycemic dysregulation were delineated for their association with 
cognitive changes. Then diabetic ketoacidosis (DKA), angiopathy, and neuropathy were 
examined as diabetic complications for their involvement in cognitive impairments. 
Lastly, body mass index and blood pressure were discussed for their relations with the 
cognitive changes. Future studies are needed to elucidate the pathogenesis of T1DM-
related cognitive impairments or dementia.  
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Introduction: T1DM and the Risk of Dementia 
As a major subtype of diabetes, type 1 diabetes mellitus (T1DM) accounts for about 5% 
of all diabetic cases [1]. The main feature of T1DM is insulin deficiency, and patients 
with T1DM are treated with different types of exogenous insulin (rapid-, short-, 
intermediate-, and long-acting insulin). Thus, T1DM is also called insulin-dependent 
diabetes mellitus (IDDM). 
Although their life span expectancy is still shorter than that of healthy people, T1DM 
patients now live much longer than they did three decades ago due to the availability of 
exogenous insulin [2, 3]; the prolonged life span thus makes them at risk for the aging-
related disease: dementia. In one retrospective study, the risk ratio for dementia in 
hospital-admitted T1DM patients was 1.65 times over the non-diabetic controls [4]. 
However, the study sample is not representative of the T1DM patient population as 
most T1DM patients are on an outpatient insulin treatment plan. Therefore, how T1DM 
is related to dementia or cognitive impairments is an unanswered question for T1DM 
patients and healthcare providers.  
We conducted a systemic review by searching the electronic databases Medline, 
EMBASE, and Google Scholar with the following keywords: type 1 diabetes, insulin-
dependent diabetes mellitus, cognitive impairment, and dementia. After removing 
duplicates and review articles, the original search returned a total of 310 results. After 
the abstracts were examined, 215 studies were excluded from further analysis as they 
were either totally irrelevant (n=135) or on type 2 diabetes mellitus (n=38), animal 
models (n=13), or non-classified diabetes (n=29). The current review has focused on 
the 59 original reports published on or after the year of 1990 from the remaining studies 
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(n=95). 
 
Cognitive Changes in T1DM Patients 
Cognitive impairments refer a continuum of severity from “mild,” which might be noticed 
by the patient or healthcare providers to “severe,” such as dementia, which interferes 
with activities of daily life or disallows a patient to function without assistance. As age is 
an important factor for cognitive impairments, cognitive changes were reviewed 
separately in young or adult T1DM patients based on their age at the time of 
neuorpsychological assessments. For young T1DM patients, the cognitive function or 
performance is presented in Table 1. Impaired executive functions [5] and motor speed 
task [6] are seen in young T1DM patients between 9 years old and 19 years old (Table 
1).  In another study, a worse performance on visual-spatial ability and memory is 
shown in pediatric T1DM patients than the control group [7]. In addition, lower verbal 
intelligence is observed in the young T1DM group than the non-diabetic control group 
[8, 9] (Table 1). However, the association between T1DM and impaired cognitive 
functions has not been observed in other studies. For example, no significant difference 
was found from a prospective study between young adults with early-onset T1DM and 
controls in general intellectual ability, memory, and emotional difficulties [10] (Table 1). 
Although students with T1DM had a significantly lower academic performance than their 
non-diabetic classmates [11] (Table 1), they and their unaffected siblings had no 
significant differences on measures of cognitive performance, academic achievement, 
or speech ability [12] (Table 1). 
For adult T1DM patients, cognitive impairments were consistently reported from 
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different studies [13, 14, 15] (Table 2). In one study, the incidence rate of cognitive 
impairments was 28% among adult patients with childhood-onset T1DM compared to 
the 5% in those without diabetes, though the study had a relatively small sample size 
and only included T1DM cases with a childhood-onset [14]. Different types of cognitive 
functions are impaired in adult patients with T1DM. For example, the adult T1DM 
patients have a worse performance in memory than nondiabetic controls [16] (Table 2). 
Study 
Design 
T1DM 
Patient Age 
(years) 
Sample 
Size 
(n) 
Cognitive Function 
Changes versus 
Controls 
Age at 
Onset 
(years) 
Disease 
Duration 
(years) 
References 
Case-control (9-19) 70 Impaired executive 
functions: concept 
formation, cognitive 
flexibility, and 
anticipation 
< 6 
(n=13); ≥6 
(n=55)  
0.9-13.7 [5] 
Case-control (9-18) 25 Impaired motor speed 
task 
  [6] 
Case-control  (4-16) 119 Worse visual-spatial 
ability and memory 
 ≥2 [7] 
Cross-
sectional 
16.2±3.1  
(9-22)  
61 Lower verbal intelligence 6.7±2.9  
(1-13) 
9.4±2.6  
(5-17.7) 
[8] 
Case-control 12.1±2.9 117 Lower verbal intelligence 6.8±3.3 ≥2 [9] 
Prospective 
Cohort 
19.3±0.5 33 No significant changes 3.3±0.3 16.0±0.5 [10] 
Cross-
sectional 
17.0±0.5  
(14.2-19.4) 
36 Lower academic 
performance 
 6.1±0.7 [11] 
Case-control 12.4±3.0  27 No significant difference <5  [12] 
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(6-20) in academic 
performance or cognitive 
functions 
 
Table 1. Cognitive function changes were studied in children/young adults (≤22 years old) with T1DM. 
Patient age, age at onset of T1DM, and disease duration are presented as mean ± standard deviation 
followed by range in years.  
 
Study Design T1DM 
Patient Age 
(years) 
Sample 
Size (n) 
Cognitive Function 
Changes versus 
Controls 
Age at 
onset 
(years) 
Disease 
Duration 
(years) 
References 
Cross-
sectional 
43.3±7.8  150 Cognitive 
impairment 
17.2±11.2 26.6±11. 4 [13] 
Case-control 49.1±6.6 97 Cognitive 
impairment 
8.0±4.2 41.0±6.2 [14] 
Case-control 39.2±6.7 55 Cognitive 
impairment 
 (6-35) [15] 
Cross-
sectional 
32.3±4.4 123 Lower performance 
in memory, 
executive function, 
and psychomotor 
speed 
12.5±5.2 19.9±3.5 [16] 
Case-control 40.4±6.2 103 Decreased 
psychomotor 
efficiency 
8.9±3.9 31.5±7.0 [17] 
Case-control  
43.4±1.1 
122 Impaired sustained 
attention 
18.2±1.0 25.4±1.0 [18] 
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Case-control 60.9±6.0 40 Slower information 
processing speed 
≤ 18 
(n=14); > 
18 (n=26)  
34.0±12.8 [19] 
 
Table 2. Cognitive function changes were studied in adult patients (>22 years old) with T1DM. Patient 
age, age at onset of T1DM, and disease duration are presented as mean ± standard deviation followed 
by range in years. 
 
In addition, adult T1DM patients have significantly reduced psychomotor efficiency [16, 
17], sustained attention [18], and information processing speed [19] (Table 2). Lastly, 
adult patients with T1DM have impaired executive functions in concept formation, 
cognitive flexibility, and anticipation [16] (Table 2). 
 
Age at Onset, Disease Duration, and Cognitive Impairments 
T1DM usually has an early age at onset (AAO) and is most often diagnosed in children 
and young adults; therefore, T1DM is also called juvenile diabetes. The developing 
brain might be more vulnerable to the effects of dysglycemia in young T1DM patients 
[20]. The AAO is an important characteristic of T1DM for influencing cognitive functions 
in patients with T1DM. A worse cognitive performance is usually associated with an 
earlier AAO. For example, learning and memory skills are more affected in pediatric 
T1DM patients with early onset than those with late onset [21]. Pathologically, more 
atrophic cerebral structural changes are found in early-onset than in late-onset young 
T1DM patients. Moreover, the medial prefrontal regions, insula, and cerebellum are the 
known rapidly developing brain regions in children, which are significantly affected by 
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the early-onset T1DM [22]. These structural changes of decreased gray matter volume 
might have long-term effects on cognitive functions. 
Similarly, current intellectual ability and information processing ability are poorer in 
young adults with early-onset T1DM (<7 years old) than those with late-onset (7-17 
years old) T1DM [23]. The fact that central brain atrophy in the early-onset T1DM group 
is more prevalent than that in the late-onset T1DM group suggests that the structural 
changes are the underlying reason for the different cognitive performance between the 
two groups. Further, the neurodevelopment in children may be affected by early-onset 
diabetes, which might have long-term deteriorating effects on cognition [23]. 
Disease duration is another important characteristic of T1DM, which is inversely 
associated with cognitive performance. Together with AAO, disease duration has been 
reported to be the strong predictors for impaired cognition functions in psychomotor 
speed, memory, processing speed, attention, working memory, verbal ability, general 
intelligence, and executive function in adult T1DM patients [13]. In addition, a delayed 
recall task performance is inversely related to the disease duration [24]. Moreover, 
disease duration could effectively predict the psychomotor speed decline in adult 
patients with T1DM [17]. However, the relationship between disease duration and 
cognitive changes has to be analyzed by taking into consideration the age factor. Not 
surprisingly, cognitive impairments in adolescent T1DM patients were reported to be 
independent of both glycemic control and disease duration in one study [5], and the 
finding suggested that T1DM might have direct pathological effects on cognitive 
functions. 
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Glycemic Control in Patients with T1DM 
Although different types of exogenous insulin are available for optimizing glycemic 
control, T1DM patients could not regulate their glucose metabolism as effectively as a 
healthy person can do with the endogenous insulin. Ironically, insulin therapy itself is 
associated with conditions of either hyperglycemia or hypoglycemia [25]. For example, 
insulin treatment is shown to be associated with the incidence rate of hypoglycemia in 
pediatric T1DM patients (9-15 years old) [26]. In addition, the glycemic control usually 
deteriorates along with the increasing duration of T1DM [5]. Thus, either hyperglycemia 
or hypoglycemia or both are commonly seen in patients with T1DM.  
 
Hyperglycemia and Cognitive Changes 
Hyperglycemia can be either chronic or induced acutely by using experimental 
technologies [27]. Chronic hyperglycemia is shown to be associated with low general 
cognitive abilities, slow fine motor speed, and low receptive language function among 
pediatric T1DM patients (<6 years old) [28]. Spelling performance is also reduced in the 
youth with T1DM with increased exposure to chronic hyperglycemia in terms of disease 
duration and level of hyperglycemia [8]. In adult T1DM patients, poor performance on 
psychomotor task, slow mental subtraction speed, and increased subtraction errors are 
seen as the effects of acute hyperglycemia when the blood glucose is above15 mmol/L 
[29]. In addition, among middle-aged participants with T1DM, cognitive impairments are 
associated with chronic hyperglycemia [14]. Although most studies have shown that the 
chronic hyperglycemia is associated with the cognitive changes in T1DM patients, the 
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same relationship is not observed on the long-term spatial memory performance in 
children with T1DM (6-18 years old) [30].  
It is worthy to note that AAO may interact with hyperglycemia for influencing cognitive 
functions in T1DM patients. For instance, hyperglycemia is negatively correlated with 
visual-spatial ability in young T1DM patients, and the correlation is stronger in these 
patients with an early AAO than in those with late AAO [7]. The level of hyperglycemia is 
another important factor for influencing cognitive functions. For instance, the level of 
hyperglycemia is negatively associated with intelligence and information processing 
speed in pediatric T1DM patients [7]. In addition, a higher HbA1c at T1DM diagnosis in 
young patients (7-17 years old) is associated with a worse performance on the long-
delay spatial delayed response task [31] as well as lower psychomotor and mental 
efficiency in adolescents (13-19 years old) [32]. Even an acute hyperglycemia achieved 
with a modified clamp technique is associated with impaired complex cognitive function 
in children with T1DM [27]. When blood glucose is in the 20- to 30-mmol/l range, the 
children’s intelligence quotient is reduced by 9.5%. Also, HbA1c values are negatively 
associated with declines in motor speed and psychomotor efficiency, according to 
another study that involved a mixed age group of T1DM patients (13-39 years old [33]). 
Therefore, the effects of chronic hyperglycemia on cognitive performance are 
associated with the AAO of T1DM, T1DM duration or both. 
 
Hypoglycemia and Cognitive Functions 
Hypoglycemia, another condition commonly seen in T1DM patients, has been studied 
for its relationship with cognitive changes as well. Attention flexibility [34], spatial ability 
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[35], and speed of information processing [34] are impaired with hypoglycemia. Early 
visual information processing and contrast sensitivity are also impaired during 
hypoglycemia in adult T1DM patients [36]. In addition, psychomotor speed and reaction 
speed are significantly decreased during hypoglycemic episodes (based on home blood 
glucose readings) for school-aged children [37]. Besides the AAO, frequency of 
hypoglycemia seems to play an important role in the cognitive changes seen in T1DM 
patients. For instance, spatial intelligence and delayed recall are reduced only with 
repeated hypoglycemic episodes, particularly when those hypoglycemic episodes occur 
before the age of 5 [9]. However, the association between hypoglycemia and cognitive 
impairments has not been observed in other reports. For example, verbal intelligence is 
not lowered by increased exposure to hypoglycemia in young T1DM patients (5-17 
years old) [9], and the number of prior hypoglycemic events is not associated with any 
changes in the cognitive functions in adult T1DM patients [13]. Moreover, sustained 
attention and intelligence are preserved during hypoglycemia induced with a 
hyperinsulineamic glucose clamp in adult T1DM patients [34].  
 
Severe Hypoglycemia (SH) and Cognitive Functions 
As the most serious side effect of insulin therapy, severe hypoglycemia (SH) affects 30-
40% of T1DM patients [33, 38]. The risk of contracting SH increases with unawareness 
of hypoglycemia as well as increased glucose variability in adult patients with long-
standing T1DM [45]. SH is defined as having low blood glucose level that requires the 
help of others for the treatment. In addition, patients with concurrent hypoglycemia (<70 
mg/dL but ≥ 40 mg/dL) and coma or seizure are also classified as having SH (10). The 
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association between SH and cognitive function changes has not been observed in 
young T1DM patients. For instance, a history of SH is not associated with the cognitive 
decrements in a T1DM patient group between 13 years old and 39 years old in a 
longitudinal study [39]. Moreover, SH is not associated with changes in either academic 
abilities [8, 21] or any other cognitive functions in children with T1DM [40]. Furthermore, 
it is still debatable how frequency of SH and AAO affect the cognitive functions in T1DM 
patients (33). For example, children with a SH history have more neuropsychological 
impairments than those without it [41]. In addition, high frequency of and early exposure 
to SH in children with T1DM negatively affect spatial long-term memory performance [9, 
30]. Nevertheless, one study reports that SH does not cause cognitive dysfunction in 
children even with severe hypoglycemia occurring during early childhood (<6 years old) 
[42]. By contrast, type 1 diabetic patients with recurrent SH are shown to have worse 
cognitive functions than those without a history of SH [43, 44].  
 
DKA and Cognitive Functions 
Diabetic ketoacidosis (DKA) is a very serious complication of T1DM that can lead to 
coma or death. This condition happens when the body does not have enough insulin for 
regulating glucose metabolism and when increased ketone production leads to 
metabolic acidosis. The prevalence rate of DKA varies from 20.9% to 75% in newly 
diagnosed T1DM patients, and the average rate is 38.8% [46-53]. The DKA is shown to 
be a risk factor for cognitive impairments in patients with T1DM. Pediatric patients with 
newly diagnosed T1DM and DKA show a definite trend for having worse cognitive 
functions than the age-matched T1DM patients without DKA [54]. For example, young 
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T1DM patients with DKA at the time of diabetes diagnosis perform worse on the spatial 
delayed response task than their non-diabetic sibling controls [31]. A history of DKA is 
also correlated with lower verbal intelligence quotient in children with T1DM [55]. In 
addition, these patients perform poorly on measures of executive function when they 
have a positive history of both DKA and hyperglycemia [55]. So the glycemic control is 
probably interacting with DKA to worsen the cognitive performance. However, a history 
of DKA is not associated with either decreased academic abilities or an increased risk of 
learning problems in children or young T1DM patients in other studies [8, 21]. The 
effects of DKA as well as its interaction with AAO, disease duration, and glycemic 
control are yet to be investigated. 
 
Angiopathy and Cognitive Functions 
Angiopathy in T1DM patients can be manifested as either microangiopathy or 
macroangiopathy or both. Retinopathy and nephropathy belong to microangiopathic 
complications of T1DM and are two common forms of diabetic microangiopathy, which 
has been suggested to be associated with cognitive impairments in patients with T1DM. 
Besides hyperglycemia, retinopathy [4, 14] and nephropathy [39, 56] are independently 
associated with decrements in psychomotor efficiency. In addition, diabetic retinopathy 
is associated with poor cognitive performance on intelligence, information processing, 
and attention/concentration ability in adult T1DM patients [57]. However, it is still 
inconclusive whether microangiopathic complications are associated with cognitive 
impairments in T1DM patients. For example, the presence of retinopathy is not a 
significant predictor of poor cognitive performance in adult patients with T1DM [13]. 
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Furthermore, microvascular complication status is not a relevant factor for cognitive 
impairments though adult T1DM patients perform poorer on general cognitive ability, 
information processing speed, and motor speed than the controls [58]. 
On the other hand, macrovascular health is associated with cognitive impairments in 
adult T1DM patients [14]. For instance, a decline in psychomotor speed can be 
predicted by macrovascular complications, duration of diabetes, proliferative 
retinopathy, and autonomic neuropathy [17].  
 
Other Factors  
Polyneuropathy is shown as the best biomedical predictor of cognitive performance in 
adult T1DM patients [59]. High body mass index (BMI) [13, 14] and hypertension [13] 
are shown as significant predictors of poor cognition functions in adult patients with 
T1DM. Specifically, systolic blood pressure can be used to predict the decline in 
psychomotor speed [17]. On the other hand, neither hypertension nor BMI are 
implicated in cognitive impairments of T1DM patients [39]. These studies are composed 
of T1DM patients who vary in age, age at onset of T1DM as well as disease duration. 
However, the discrepancy of these findings warrants further studies to examine 
hypertension’s and BMI’s roles in the cognitive changes of T1DM patients. 
 
Conclusion 
This review has focused on the cognitive impairments in young and adult T1DM 
patients. The cognitive changes have been examined from the following perspectives: 
AAO and duration of T1DM, glycemic dysregualtion, diabetic ketoacidosis (DKA), and 
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angiopathy. In addition, other factors such as blood pressure, BMI, and neuropathy are 
discussed for their relations with the cognitive changes in T1DM patients. In children 
with T1DM, impaired cognitive functions or poor cognitive performance were observed 
in most studies (Table 1). In contrast, the impaired cognitive functions were seen more 
consistently in studies with adult T1DM patients (Table 2). Very few studies have a 
follow-up long enough to show whether poor cognitive performance and/or functions in 
childhood last into adulthood. However, some evidence [22, 23] has shown early-onset 
T1DM is associated with brain structural changes, which might have long-lasting effects 
on cognitive functions. However, prospective studies with a long follow-up design will be 
useful for investigating the long-term effects of early-onset T1DM on cognitive functions. 
In addition, future studies are needed to elucidate the underlying mechanism of T1DM-
related cognitive impairments or dementia. 
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